Answers are grounded in this paper and cite their sources.
This narrative Perspective highlights the resurgence of Mycoplasma pneumoniae in children, suggesting urgent clinical considerations and surveillance priorities.
Mycoplasma pneumoniae infections declined sharply during COVID-19 non-pharmaceutical interventions but have resurged in multiple regions after restrictions were lifted. This narrative Perspective synthesizes recent epidemiologic and molecular observations and emphasizes children as a key reservoir sustaining community transmission. We highlight how asymptomatic carriage and prolonged upper-airway detection complicate interpretation of PCR results, and we discuss the clinical implications of macrolide-resistant M. pneumoniae (MRMP), including pragmatic, age-stratified management considerations. Finally, we outline priorities for surveillance and for translating genomic signals into simplified clinical pathways, particularly in high-MRMP settings.
No takes yet. Share an insight, caveat, or question.
Takeshi Saraya (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: